Showing results (171-180 of 181) with videos related to
Sort By:
Pageof 19
Allergy|June 19, 2023
A European-Japanese study on peach allergy: IgE to Pru p 7 associates with severityE J J Kallen, A Revers, M Fernández-Rivas, et al.Pulmonology|November 25, 2022
Identification by cluster analysis of patients with asthma and nasal symptoms using the MASK-air® mHealth appJ Bousquet, B Sousa-Pinto, J M Anto, et al.Clinical and Translational Allergy|November 30, 2016
Allergy immunotherapy across the life cycle to promote active and healthy ageing: from research to policies: An AIRWAYS Integrated Care Pathways (ICPs) programme item (Action Plan B3 of the European Innovation Partnership on active and healthy ageing) and the Global Alliance against Chronic Respiratory Diseases (GARD), a World Health Organization GARD research demonstration projectM A Calderon, P Demoly, T Casale, et al.Pulmonology|August 5, 2023
Adherence to inhaled corticosteroids and long-acting β2-agonists in asthma: A MASK-air studyB Sousa-Pinto, R Louis, J M Anto, et al.Allergy|June 11, 2017
Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA-ARIA) - EIP on AHA Twinning Reference Site (GARD research demonstration project)J Bousquet, I Agache, M R Aliberti, et al.The European Respiratory Journal|June 14, 2014
Integrated care pathways for airway diseases (AIRWAYS-ICPs), , , et al.Allergy|February 17, 2023
Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA-MeDALL hypothesisJ Bousquet, E Melén, T Haahtela, et al.The Journal of Allergy and Clinical Immunology|October 9, 2012
Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needsJ Bousquet, H J Schünemann, B Samolinski, et al.Allergy|July 7, 2015
MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementationJ Bousquet, H J Schunemann, J Fonseca, et al.Clinical and Translational Allergy|February 28, 2017
Erratum to: Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)J Bousquet, J Farrell, G Crooks, et al.Pageof 19